Quadrise CEO outlines significant milestones as it progresses its biofuel technology

–News Direct–

Quadrise PLC (AIM:QED) CEO Jason Miles joins Proactive's Stephen Gunnion with an update on the significant advancements the company is making in biofuel technology.

Quadrise's successful completion of a fuel trial in Morocco stands as a notable achievement, demonstrating the potential of MSAR as a cost-effective alternative for industrial fuel needs. This trial marked the first commercial-scale demonstration of bioMSAR in an industrial setting, highlighting Quadrise's pioneering role in the industry.

Miles elaborated on the trial's success, noting the substantial fuel consumption of the tested unit, comparable to a large container ship. The trial impressively met stringent emission standards, showcasing biofuel's viability in reducing CO2 emissions by over 25%. The stability of MSAR and bioMSAR, maintained for over 12 months, further attests to the fuel's reliability.

Looking forward, Quadrise is preparing a technical report for the client and initiating discussions for potential EMSA supply starting in 2024. This includes considering trials at other sites, reinforcing the company's commitment to energy decarbonization. Miles also touched on other projects, including a marine program with MSC, set for a commercial vessel trial in 2024, and a US low-carbon fuels project with Valco.

These initiatives, alongside strategic partnerships for biofuel development, underscore Quadrise's proactive approach to sustainable fuel solutions.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

[email protected]

View source version on newsdirect.com: https://newsdirect.com/news/quadrise-ceo-outlines-significant-milestones-as-it-progresses-its-biofuel-technology-308048899

Quadrise PLC

comtex tracking

COMTEX_444086627/2655/2023-11-27T07:45:19

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Smart Herald journalist was involved in the writing and production of this article.